Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes

Cited by (191)

Items 101–191 of 191

  1. Cardiac autonomic neuropathy: impact on severe hypoglycemic unawareness and orthostatic hypotension in diabetic dysautonomia, a case series and review
    Chao Wu, Rakesh Reddy Devireddy, Andrew Zazaian, Sujata Kambhatla, Opada Alzohaili, Chadi Saad · 2024 · Cardiovascular Endocrinology & Metabolism
  2. Technology for type 1 diabetes: what impact will it have?
    Maria E. Craig · 2024 · The Lancet Diabetes & Endocrinology
  3. Early Stages of Automated Insulin Delivery
    Howard Zisser, Roman Hovorka, Ananda Basu, Tadej Battelino, Charlotte K. Boughton, Marc D. Breton, Bruce A. Buckingham, Sue A. Brown, Daniel R. Cherñavvsky, Eyal Dassau et al. · 2025 · Diabetes Technology & Therapeutics
  4. Letters to the Editor
    Ailsa Marshall, Lena Lim, Macdonald Allyson, Lesley Sharon Youde, Ann Nillsen, Nghi Hoang Bui, Nicky Townsend, Stone Monique, Amy Wanaguru, Kim A Ramjan et al. · 2023 · Journal of Paediatrics and Child Health
  5. How can we reach the target of glucose control in type 1 diabetes?
    Z. Bloomgarden · 2023 · Journal of Diabetes
  6. Artificial Pancreas: The First 20 Years
    Francis J. Doyle, Boris P. Kovatchev · 2025 · Journal of Diabetes Science and Technology
  7. Daytime and nighttime glycemic control with control-IQ technology vs. standard therapy in type 1 diabetes: a systematic review and meta-analysis with trial sequential analysis and GRADE assessment
    Rahma Mogahed Rateb, Ammar Salah, Ahmed Kertam, Youssef Adel Youssef Ashmawi, Nourhan Hatem Mahmoud, Eslam Afifi, Ahmed Bayoumi, Salma Allam, Mohamed Saad Rakab · 2025 · Diabetology & Metabolic Syndrome
  8. Improvement in Glucometric Outcomes After Control-IQ Initiation in Pediatric and Adolescent Type 1 Diabetes Patients: The Impact of Basal Time in Range
    Ana Gómez‐Perea, Alfonso Lendínez Jurado, Silvia Gallego Gutiérrez, Fuensanta Guerrero‐del‐Cueto, Ana García-Ruiz, Cristina López-De La Torre, Fernando Cardona, Isabel Leiva Gea · 2025 · International Journal of Molecular Sciences
  9. Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021
    Janna Manjelievskaia, Viral N. Shah, Anders L. Carlson, Diana M. Isaacs, Sharon M. Wang, Jordan E. Pinsker, Laurel H. Messer, Kimberly Walsh McDermott, Kevin Lavelle, Stephanie Wall et al. · 2025 · Diabetic Medicine
  10. The results of ProHCL: Patient-reported outcomes in people living with type 1 diabetes on hybrid closed-loop insulin pump therapy − experiences from the NHS England pilot
    Tomás Patrick Griffin, Jennifer Hagan, Radhika Chauhan, Thomas Simon James Crabtree, Dawn Ackroyd, Jackie Elliott, Parth Narendran, Zosanglura Bawlchhim, Emma G. Wilmot, Michelle Hadjiconstantinou et al. · 2026 · Diabetes Research and Clinical Practice
  11. Factors Associated With Time to Automated Insulin Delivery System Initiation in Youth With Type 1 Diabetes
    Neha Parimi, Charles Wu, Jaydan Ziglar, Elizabeth A. Brown, Aniket R Sidhaye, Nestoras Nicolas Mathioudakis, Risa M. Wolf · 2026 · Journal of Diabetes Science and Technology
  12. Building the evidence to address disparities in type 1 diabetes (BEAD-T1D): methods and design of a study examining barriers and promoters to diabetes device use in families with public insurance
    Lauren E. Figg, Ricardo Medina Peñaranda, Daniel Garfias Silva, Sarah J. Hanes, Gary Michael Shaw, Lisa Jo Chamberlain, Diana M. Naranjo, Jennifer K. Raymond, David M. Maahs, Korey K. Hood et al. · 2026 · Frontiers in Endocrinology
  13. Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials
    Qiongyan Lin, Y Zhou, MENGYUN LEI, Ping Ling, YING NI, Ziqing Lin, Daizhi Yang, Wen Xu, Hongrong Deng, Jinhua Yan · 2026 · Diabetic Medicine
  14. Secular trends in HbA1c levels among children and adolescents with type 1 diabetes
    Jung Chou, Chao‐Hsu Lin, Shih-Kai Kevin Lin, Yann-Jinn Lee, Chi-Yu Huang, Yu-En Kao, Jia-Cian Yu, Wei‐Hsin Ting · 2026 · Frontiers in Endocrinology
  15. Associations between body composition and glycemic control: an exploratory analysis of bioelectrical impedance parameters in adolescents with type 1 diabetes
    Arianna Torre, Bruno Bombaci, Mattia Papa, Sara Aramnejad, Mariarosaria La Rocca, Alessandra Di Pisa, Angela Alibrandi, Fortunato Lombardo, Giuseppina Salzano, Stefano Passanisi · 2026 · Diabetology & Metabolic Syndrome
  16. Automated Insulin Delivery Use Among Preschool-Age Children With Type 1 Diabetes: A T1D Exchange Multicenter Analysis
    Risa M. Wolf, EMMA L. OSPELT, DHRUVI VORA, Ori Odugbesan, Elizabeth A. Brown, Jenise C. Wong, Christine A. March, Nestoras Nicolas Mathioudakis · 2026 · Journal of Diabetes Science and Technology
  17. Continuous Glucose Monitoring Metrics and Risks of Severe Hypoglycemia and Diabetic Ketoacidosis in Type 1 Diabetes: A Pooled Analysis
    Jiahuan Helen He, Natalie Rula Daya, Scott L. Zeger, Justin Basile Echouffo-Tcheugui, Michael Fang, Elizabeth Selvin · 2026 · Diabetes Care
  18. Diabetes Technology in the School Setting for Preschool-Aged Children
    Raquel M. Gupta, Daniel J. DeSalvo, Kelly Hicks, Sarah Renee Kelly, Serife Uysal, Crystal Woodward, Sarah K. Lyons · 2026 · Journal of Diabetes Science and Technology
  19. Diabetes in the Pediatric Age Group: A Case Series and Review of Literature
    Jesús Rodolfo Valenzuela-Ruiz, Gustavo Francisco Bobadilla-Olaje, Jesús René Tadeo Calleja-López, Enrique Ruibal-Tavares, Cristian Noé Rivera-Rosas, Luis José Aguilera-Duarte, Jesús Omar Ruiz-Quiroz · 2023 · Journal of Pediatrics Review
  20. Automatische Insulindosierung (AID)
    J. Ware · 2024 · Die Diabetologie
  21. Automatische Insulindosierung (AID) bei Kindern und Jugendlichen mit Typ-1-Diabetes
    Martin Tauschmann · 2024 · Die Diabetologie
  22. Automated insulin delivery systems in the treatment of diabetes: Benefits, challenges, and practical considerations in pediatric patients
    Patricia Enes Romero, María Güemes, Blanca Guijo, Gabriel Ángel Martos‐Moreno, Jesús Pozo Román, Jesús Argente · 2024 · Endocrinología Diabetes y Nutrición (English ed )
  23. Enhanced Metabolic Control in a Pediatric Population with Type 1 Diabetes Mellitus Using Hybrid Closed-Loop and Predictive Low-Glucose Suspend Insulin Pump Treatments
    Irina Bojoga, Sorin Ioacără, Elisabeta Andreea Malinici, Victor Chiper, Olivia Georgescu, Anca Mirela Sîrbu, Simona Vasilica Fica · 2024 · Pediatric Reports
  24. EFFECTIVENESS OF HYBRID CLOSED-LOOP SYSTEMS IN PEDIATRIC TYPE 1 DIABETES MELLITUS MANAGEMENT: A SYSTEMATIC REVIEW
    Justyna Grudziąż-Sękowska, Kuba Bartłomiej Sękowski, Zuzanna Grześczyk-Nojszewska, Jarosław Pinkas, Janusz Ostrowski, Mateusz Jankowski · 2025 · Health Problems of Civilization
  25. Early Stages of Automated Insulin Delivery
    Howard Zisser, Roman Hovorka, Ananda Basu, Tadej Battelino, Charlotte K. Boughton, Marc D. Breton, Bruce A. Buckingham, Sue A. Brown, Daniel R. Cherñavvsky, Eyal Dassau et al. · 2025 · Journal of Diabetes Science and Technology
  26. Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes
    R Paul Wadwa, Roy W. Beck, Marc D. Breton · 2023 · New England Journal of Medicine
  27. Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology
    Viral N. Shah, Halis Kaan Aktürk, Alex C. Trahan, Nicole Piquette, Alex Wheatcroft, Elaine M. Schertz, KAREN CARMELO, Lars Müeller, KIRSTIN N. WHITE, Larry Fu et al. · 2024 · Journal of Diabetes Science and Technology
  28. Continuous and Intermittent Glucose Monitoring in 2024
    Klemen Dovč, Bruce W. Bode, Tadej Battelino · 2025 · Diabetes Technology & Therapeutics
  29. An artificial nervous system for communication between wearable and implantable therapeutics
    Ramy W. Ghanim, Yoon Jae Lee, Garan Byun, Joy Jackson, Julia Z. Ding, Elaine K. Feller, Eugene Kim, Dilay Aygun, Anika Kaushik, Alaz Cig et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Artificial Pancreas: The First 20 Years*
    Francis J. Doyle, Boris P. Kovatchev · 2025 · Diabetes Technology & Therapeutics
  31. Utility of Technology in the Treatment of Type 1 Diabetes: Current State of the Art and Precision Evidence
    Laura M. Jacobsen, Jennifer L. Sherr, Elizabeth G. Considine, Angela Chen, Sarah Peeling, Margo Hulsmans, Sara Charleer, Marzhan Urazbayeva, Mustafa Tosur, SELMA A. ALAMARIE et al. · 2023 · medRxiv
  32. La pagina gialla
    Alessandro Ventura · 2023 · Medico e Bambino
  33. Hybrid closed‐loop control is superior to standard care in young children with type 1 diabetes
    ISKANDAR RAUF IDRIS · 2023 · Diabetes Obesity and Metabolism Now
  34. Clinical Rounds
    2023 · Nursing
  35. Hybrides Closed-Loop-System verbessert Glucosekontrolle bei Kleinkindern
    Ulrike Andres · 2023 · Diabetologie und Stoffwechsel
  36. Erste pädiatrische Nutzung eines AID-Systems mit automatischem Korrekturbolus in Deutschland
    Thekla von dem Berge, Sarah Biester, K Remus, Felix Reschke, Britta Klusmeier, Kerstin Adolph, Olga Kordonouri, Thomas Danne, Torben Biester · 2023 · Diabetologie und Stoffwechsel
  37. Hybrides Closed-Loop-System verbessert Glucosekontrolle bei Kleinkindern
    2023 · Ernährung & Medizin
  38. Optimizing Glycemic Outcomes for Children with Type 1 Diabetes
    Vickie Wu, Lauryn Choleva, Meredith A. Wilkes · 2023 · Endocrinology and Metabolism Clinics of North America
  39. Diabetic Children: Be Dogmatic About Outcome and Flexible in Approach
    Harry Dorchy · 2023 · Medicine and Clinical Science
  40. Beta Cell Replacement Cellular Products: Emerging Regulatory Perspectives and Considerations for Program Development
    B Schneider · 2023 · Springer eBooks
  41. Diabetes Technology and Therapy in the Pediatric Age Group
    David M. Maahs, Priya Prahalad, Darja Šmigoc Schweiger, Shlomit Shalitin · 2024 · Diabetes Technology & Therapeutics
  42. Die COVID-19-Pandemie als Katalysator für telemedizinische Therapieangebote: eine Studie über Kinder und Jugendliche mit Diabetes mellitus Typ 1 in Deutschland und Österreich
    Katharina Klauser, Julian Ziegler, Petra Augstein, Stefanie Schmid, Simone von Sengbusch, Felix Reschke, Angela Galler, Sabine E. Hofer, Silke Schmidt, Marina Sindichakis et al. · 2024 · Diabetologie und Stoffwechsel
  43. Automated Insulin Delivery in Women With Pregnancy Complicated by Type 1 Diabetes
    Tara Lee, Corinne Collett, Simon Bergford, Sara Hartnell, ELEANOR M. SCOTT, Robert S. Lindsay, Katharine F. Hunt, David R. McCance, Katharine D. Barnard-Kelly, David Rankin et al. · 2024 · Obstetrical & Gynecological Survey
  44. Typ-1-Diabetes – Neue Aspekte in Therapie & Technologie 2024
    Thomas Schimmel, Thomas Ebert · 2024 · Die Diabetologie
  45. Sistemas de infusión automatizada de insulina en el tratamiento de la diabetes: beneficios, retos y consideraciones prácticas en la edad pediátrica
    Patricia Enes Romero, María Güemes, Blanca Guijo, Gabriel Ángel Martos‐Moreno, Jesús Pozo Román, Jesús Argente · 2024 · Endocrinología Diabetes y Nutrición
  46. Warum Kleinkinder auf moderne Systeme länger warten müssen
    Stephanie Balz · 2024 · Diabetes aktuell
  47. Le numérique en ETP : une révolution en marche
    Jean-David Cohen · 2024 · Education thérapeutique du patient - Therapeutic patient education
  48. CHRONIC KIDNEY DISEASE IN CHILDREN WITH TYPE 1 DIABETES MELLITUS
    Елена Петровна Батаева, T. E. Znamenskaya, Ольга Васильевна Балдынюк, L. R. Kalinina · 2025 · Zabajkalʹskij medicinskij vestnik
  49. Pharmacotherapy of type 1 diabetes - part 2 Today
    Marc S. Rendell · 2025 · Expert Opinion on Pharmacotherapy
  50. Diabetes Technology and Therapy in the Pediatric Age Group
    David M. Maahs, Priya Prahalad, Darja Šmigoc Schweiger, Shlomit Shalitin · 2025 · Diabetes Technology & Therapeutics
  51. Automated insulin delivery systems in children and adolescents with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
    Baoqi Zeng, Le Gao, Qingqing Yang, Hao Jia, Feng Sun · 2025
  52. More options for young children with type 1 diabetes
    Charlotte K. Boughton · 2025 · The Lancet Diabetes & Endocrinology
  53. AID-System bei breit gemischtem Patientenkollektiv mit Typ-2-Diabetes geprüft
    Andreas Thomas · 2025 · Info Diabetologie
  54. CGM Metrics in Adolescents with Type 1 Diabetes and Diabetes Distress in the Promoting Resilience in Stress Management (PRISM-T1D) Trial
    Michael L. Ferm, Daniel J. DeSalvo, Chuan Zhou, Miranda C. Bradford, Faisal Saleem Malik, Maeve B. O’Donnell, Catherine Pihoker, Abby R. Rosenberg, Joyce P. Yi‐Frazier, Marisa E. Hilliard · 2025 · Diabetes Technology and Obesity Medicine
  55. Real-World Duration of Dexcom G7 Continuous Glucose Monitor Wear in Youth and Young Adults with Type 1 Diabetes
    Brynn E. Marks, Andrew Rearson, Melissa Andrews Rearson, Robert Gallop, Jacquelyn A. Hatch-Stein · 2025 · Diabetes Technology & Therapeutics
  56. EndoCompass Project: Research Roadmap for Diabetes, Obesity, and Metabolism
    Chantal Mathieu, Manuela Meireles, Uberto Pagotto, Martin Wabitsch, Indraneel Banerjee, Alberto Bartolomé, Tadej Battelino, Julia Beck, Francesco Chiarelli, Diva D. De León et al. · 2025 · Hormone Research in Paediatrics
  57. Additional file 1 of Glucose control and psychosocial outcomes with use of automated insulin delivery for 12 to 96 weeks in type 1 diabetes: a meta-analysis of randomised controlled trials
    Godoi, Amanda, Reis Marques, Isabela, Padrão, Eduardo M. H., Mahesh, Ashwin, Hespanhol, Larissa C., Riceto Loyola Júnior, José Eduardo, Isabela A F de Souza, Vittoria Caporal S Moreira, Silva, Caroliny H., Isabele Ayumi Miyawaki et al. · 2024 · Figshare
  58. Insulin pumps and artificial pancreas
    Konstantinos P. Markakis, Andriani Vazeou · 2025 · Elsevier eBooks
  59. AI in Treatment and Patient Care
    Lobat Tayebi, Sachin Shetty, Seyedmisagh Imani · 2026 · Springer eBooks
  60. Modernes Diabetesmanagement bei Kindern und Jugendlichen mit Diabetes mellitus Typ 1
    Angela Galler · 2026 · Pädiatrie up2date
  61. The Virtual Diabetes Control and Complications Trial #4: Relationship of HbA1c and Continuous Glucose Monitoring Metrics with Severe Hypoglycemic Events
    Anika Bilal, William B. Horton, Boris P. Kovatchev, Anna Casu, RE Pratley, Lauren Kanapka, Roy W. Beck · 2026 · Diabetes Technology & Therapeutics
  62. Attitudes and Barriers Toward Automated Insulin Delivery Systems Among Health Care Providers in Germany: A Network Analysis From the dt-Report
    Dominic Ehrmann, Timm Roos, Jens Kröger, Hansjörg Mühlen, Winfried Keuthage, Andreas Lueg, Nikolaus Scheper, Lutz Heinemann, Derek Brandt, Norbert Hermanns et al. · 2026 · Journal of Diabetes Science and Technology
  63. Prevalence, duration, and clinical implications of Continuous Glucose Monitor (CGM) measurement limit capping in type 1 diabetes
    John F. Mulley · 2026 · medRxiv
  64. Patient satisfaction and performance of the A8+ TouchCare Nano in children and adolescents with type 1 diabetes mellitus
    Konstantina Kosta, Maria G. Grammatikopoulou, Ilektra Toulia, Penelope Smyrnaki, Eleni G. Paschalidou, Anastasios Vamvakis, Antonios Bogiatzoglou, Christos Tzimos, Kyriaki Tsiroukidou · 2026 · World Journal of Clinical Pediatrics
  65. Automated insulin delivery in type 2 diabetes: a meta-analysis of randomized trials protocol
    Luis Gordillo-Rosas, Cindy Lee Cajachagua-Pucuhuaranga, Julian Adan Santa Cruz-Venegas, Luis Mateus Urrutia-Osorio, Samir Alexander Pantoja Meneses, Jimena Lozano-Núñez, Oriana Rivera-Lozada, Cesar Bonilla-Asalde, Joshuan J. Barboza · 2026 · Systematic Reviews
  66. Targeting Sleep Quality Dimensions: Impact of Hybrid Closed-Loop Technology on Caregivers of Children and Adolescents with Type 1 Diabetes
    Alfonso Lendínez Jurado, Ana García-Ruiz, Fuensanta Guerrero‐del‐Cueto, Ana Gómez‐Perea, Silvia Gallego Gutiérrez, Carlos Fuentes-Lupiáñez, Cristina López-De La Torre, Isabel Leiva Gea · 2026 · Endocrines
  67. First Use of Control-IQ+ Technology in Newly Indicated Populations
    Kimia Z. Assadi, Edwin W. D’Souza, Jordan E. Pinsker, Laurel H. Messer · 2026 · Diabetes Technology & Therapeutics
  68. Unifying relative and absolute risk: a general family of continuous risk indices for binary outcomes
    Cynthia Zou, Changyong Feng · 2026 · Epidemiologic Methods
  69. Real-world outcomes of hybrid closed-loop insulin pump therapy in UK children and young people with type 1 diabetes and high HbA1c: a multicentre retrospective cohort study
    Anna Caitlin King, Peter Christian, Paul Bassett, Edward Holloway · 2026 · Archives of Disease in Childhood
  70. Real‐world outcomes using the Tandem Mobi insulin pump with Control‐ IQ + technology and Dexcom G7
    Edwin W. D’Souza, Jessica R. Castle, Kimia Z. Assadi, Laurel H. Messer, Jordan E. Pinsker · 2026 · Diabetic Medicine
  71. Differences in Achieving Stringent Glycemic Targets Among Youth with Type 1 Diabetes: A SWEET Registry Study
    Klemen Dovč, Beata Mianowska, Claudia Boettcher, Roque Cardona‐Hernandez, Thekla von dem Berge, Elizabeth Ann Davis, Ioanna Kosteria, Marco Marigliano, Birgit M. Rami-Merhar, Mauro Scharf et al. · 2026 · Diabetes Technology & Therapeutics
  72. Prevalence, duration, and clinical implications of continuous glucose monitor measurement limit capping in type 1 diabetes
    J. Mulley · 2026 · medRxiv
  73. Beyond TIR: the impact of technology on glucose variability in a cohort of preschool children with T1D
    Mariangela Martino, Lorena Matonti, Annalisa Deodati, Maria Elisa Amodeo, Paolo Ciampalini, Valentina Pampanini, Novella Rapini, Francesca Silvestri, Rosanna Squintani, Antonella Lorubbio et al. · 2026 · Diabetology & Metabolic Syndrome
  74. Relationship between participant-reported outcomes, residual beta cell function and metabolic parameters in youth with newly diagnosed type 1 diabetes
    Peter Nicholas Taylor, Wai-Yee Cheung, Joe Lagorio Price, Charlotte K. Boughton, Jane Bowen‐Morris, Hayley Anne Hutchings, Stephanie Jean Hanna, Steve Luzio, Danijela Tatović, Ashish Marwaha et al. · 2026 · Diabetologia
  75. From algorithm to alarm: a narrative review on insulin delivery innovation
    Noor ul Ain Saleem, Faraz Arshad, Maria Qadri, Muhammad Saqlain Mushtaq, Mishaim Khan, Pakeeza Shakoor, T Patel, Anaya Noor, Nana Sardarova, Nikhilesh Anand et al. · 2026 · Annals of Medicine and Surgery
  76. Advanced Technology in Diabetes: Sensors and Pumps
    Gregory P. Forlenza · 2026 · Elsevier eBooks
  77. INSIGHT: Ingest and Standardize Glucose Harmonization Tool
    Ben Ehlert, Krish Shah -, Dev Katarya, Yue Wu, Tao Wang, Michael P. Snyder · 2026 · Journal of Diabetes Science and Technology
  78. Automated Insulin Delivery in Very Young Children: The Next Challenge Is Access
    Hussein Zaitoon · 2026 · Journal of Diabetes Science and Technology
  79. Efficacy and safety of hybrid closed-loop systems in children aged < 7 years with type 1 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Tingting Zhang, Na Wang, Bo Wang, Menghao Wang, Jia Zhang · 2026 · Pediatric Diabetes
  80. Efficacy of Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Systematic Review of Randomized Controlled Trials
    Rania Edris, Thowiba Awad Obaidalla Mohamad, Eman Ali Mohamed Hassan, Ammar Mohammad Suliman Hamza, Maali Shukri AbdElkhier DafaAlla, Samah Dafallah Nimir Ahmed · 2026 · Cureus
  81. Diabetes Technology in Children
    Yongwen Zhou, Benjamin John Wheeler · 2026 · Springer eBooks
  82. Dose‐Normalised Time in Range ( dn‐TIR ) Improves Following Hybrid Closed‐Loop ( HCL ) Therapy in Type 1 Diabetes: A Real‐World Cohort Study From Australia and the United Kingdom
    Jude Wellens-Mensah, Akash Konantambigi, Keimee Lopez, Jessica Triay, Vasant V. Shenoy, Gaurav Puri, Emma G. Wilmot, Thozhukat Sathyapalan, Harshal Deshmukh · 2026 · Diabetes Obesity and Metabolism
  83. Toward fully algorithmic care for type 1 diabetes: The case for AI autonomy, and a recalibrated role for the diabetologist in an ageing type 2 diabetes population
    Mounzer Maaz, Samar Maaz, Islam Maaz, Randa Dardari, Helene Dardari, Dured Dardari · 2026 · PLOS Digital Health
  84. An in-body networking system for communication between wearable and implantable therapeutics
    Ramy W. Ghanim, Yoon Jae Lee, Garan Byun, Joy M. Jackson, Julia Z. Ding, Jihoon Park, Markella Bibidakis, Elaine Feller, Eugene Kim, Dilay Aygun et al. · 2026 · Science
  85. Artificial intelligence-driven therapeutics for disease modification in type 1 diabetes: a digital public health and clinical translation framework
    Krish Hirani, Camila Blaschke, Carlota Olloqui, Rahul Mittal · 2026 · Frontiers in Public Health
  86. Modernes Diabetesmanagement bei Kindern und Jugendlichen mit Diabetes mellitus Typ 1
    Angela Galler · 2026 · Diabetes aktuell
  87. Automated Insulin Delivery Systems in Youth with Diabetes
    Mariam Mroweh, Samuel Thompson, Laya Ekhlaspour · 2026 · Endocrinology and Metabolism Clinics of North America
  88. Tail-Risk-Aware Model Predictive Control for Hypoglycemia Mitigation in Automated Insulin Delivery
    Kaiyuan Zhang, Congyu Han, Hexing Guo, Shuo Kang, Shuji Jing, Chunrui Wang, Tianyi Zang, Yanli Zhao · 2026 · Metabolites
  89. Efficacy and Safety of Automated Insulin Delivery Systems in Children and Adolescents With Type 1 Diabetes: A Systematic Review of Randomized Controlled Trials
    Rakhi Jain, Piyush Upadhyay · 2026 · Cureus
  90. Type 1 Diabetes in the Youngest: From Distinct Needs to New Frontiers in Care
    Diletta Maria Francesca Ingrosso, Olivier Gaetan Polle, Kévin Perge, Julie Pélicand, Gaëlle Vermillac, Cécile Godot, Alix Besançon, FRANCESCO CHIARELLI, Jacques Beltrand · 2026 · Hormone Research in Paediatrics
  91. Increasing Insulin Pump Use in Youth with Type 1 Diabetes While Addressing Disparities
    Kimberly K. Vidmar, Rachel J. Fenske, Whitney N. Beaton, M. Tracy Bekx, Elizabeth A. Mann · 2026 · Pediatric Quality and Safety